A cross-study analysis of Xarelto indicates that neither the timing nor the content of a meal appear to clinically change the level or effectiveness of the blood thinner, according to a study published in The Journal of Clinical Pharmacology. The highly selective oral direct factor Xa inhibitor is approved by the Food and Drug Administration (FDA) to prevent strokes in patients with the heart condition atrial fibrillation. It is also used to treat or prevent deep vein thrombosis and pulmonary embolism, and to prevent blood clots in patients who have recently undergone hip or knee replacement surgery. Xarelto, which contains ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.